Desmopressin Acetate Spray Shortage: Current Supply Updates and Manufacturer Status
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA has reported a current shortage of Desmopressin Acetate Spray due to shipping delays, with replenishment from Apotex Corp. expected in mid-March 2026.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Desmopressin Acetate.
What's in Shortage
Desmopressin Acetate Spray (Brand Name: DESMOPRESSIN ACETATE) is currently listed in shortage. This medication is used within the Hematology therapeutic category and is supplied as a spray in a 10 ug dosage form (NDC 60505-0815-0).
Which Manufacturers Are Affected
Apotex Corp.
- Status: Unavailable
- Notes: The next replenishment is currently expected in Mid March 2026. This specific presentation of Desmopressin Acetate does not require refrigeration.
- Contact Information: 800-706-5575
Why There's a Shortage
The shortage is due to a delay in shipping of the drug. No further details regarding the logistics delay were provided in the official report.
What Patients Should Do
If you are currently prescribed Desmopressin Acetate Spray, please consider the following steps:
- Consult your healthcare provider: Discuss your treatment plan and ask about suitable alternatives for your condition.
- Talk to your pharmacist: Check on local stock levels and see if they can assist in locating the medication at other branches.
- Contact the manufacturer: You may reach out to Apotex Corp. at 800-706-5575 for specific questions regarding their supply timeline.
Disclaimer: Patients should always consult their healthcare provider for medical advice and treatment options. Do not change your medication regimen without professional guidance.
Source
Information sourced from the FDA Drug Shortage Database.
- Initial Posting Date: 03/12/2021
- Last Updated: 03/04/2026
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.